Differences in somatic TP53 mutation type in breast tumors by race and receptor status
Nijole Pollock, Johnny R. Ramroop, Heather Hampel, Melissa A. Troester, Kathleen Conway, Jennifer J. Hu, Jo L. Freudenheim, Olufunmilayo I. Olopade, Dezheng Huo, Elad Ziv, Susan L. Neuhausen, Patrick Stevens, Joseph P. McElroy, Amanda E. Toland
Topics & Concepts
Breast cancerSomatic cellMissense mutationMutationTriple-negative breast cancerGermline mutationBiologyOncologyInternal medicineEstrogen receptorCancer researchCancerMedicineGeneticsGeneBreast Cancer Treatment StudiesCancer Genomics and DiagnosticsBRCA gene mutations in cancer